首页
登录
职称英语
Last year, when President George W. Bush announced that federal funds could b
Last year, when President George W. Bush announced that federal funds could b
游客
2025-01-03
11
管理
问题
Last year, when President George W. Bush announced that federal funds could be used to support re search on human embryonic stem cells, he mandated that only those cell lines that existed at the time would qualify for such support. More than a year later it’s becoming increasingly clear that these existing cell lines are inadequate. Unless more are created, the research slowdown may exact a staggering cost in terms of human suffering.
Since this announcement, the U. S National Institutes of Health has tried to stimulate research on the existing cell lines with new funding and efforts to streamline the initially cumbersome process of obtaining approved cells. However, whether there are 60 cell lines, as originally stated, or nine, as now appear to be available to NIH-funded investigators, the number is not adequate. Given the genetic diversity within the population, scientists need access to new cell lines if they are to come up with the most effective cell therapies.
The issue is partly one of safety. In conducting research with human participants, we must minimize risks. The most effective cell line might not be the safest. When developing a new medicine, a large number of molecules must be screened to find a balance between effectiveness and safety. The same is true with cells: In the context of cell therapy, it will be important to minimize unwanted immune reactions and inflammation. This requires selection from a large number of cell lines to obtain the best match.
It’s clear from experiments with animals that stem--cell therapies can reduce human suffering. Parkinsonian mice have been cured with embryonic stem cells that were programmed to become dopamine-secreting, replacement nerve cells. Soon, cells induced to make insulin in tissue cultures will be used in attempts to treat diabetic mice. Similar successes have been achieved in animal models of spinal cord injury, heart failure and other degenerative disorders. We are at a frontier in medicine where tissues will be re stored in ways that were not imaginable just a few years ago. The ethical issues raised by human-embryo research are profound. The human costs of restricting this research must be taken into account as well. The cost in dollars of delaying new stem-cell research is difficult to estimate. It might measure in the hundreds of billions of dollars, especially if one adds the lost productivity of individuals who must leave work to care for victims of degenerative disorders.
A less obvious, but real, cost is the damage to the fabric of America’s extraordinary culture of inquiry and technical development in biomedical science. Our universities and teaching hospitals are unparalleled. We attract the very best students, scientists and physicians from around the world. But these institutions are fragile. Research and education play key roles in attracting the best physicians. A crippled research enterprise might add an unbearable stress with long-lasting effects on the entire system. If revolutionary new therapies are delayed or outlawed, we could be set back for years, if not decades.
To steer clear of controversy, some investigators will redirect their research. Others will emigrate to countries where such research is allowed and encouraged. Some will drop out entirely. The pall cast over the science community could extend far beyond stem-cell research. Many therapies have emerged from collaboration between government-sponsored researchers and private enterprise. Few of these discoveries would have emerged ii, for instance, recombinant DNA research had been outlawed 30 years ago. We face the same type of decision today with limits placed on human embryonic stem cells.
Safeguards will be necessary. But if we do not proceed embracing the values of objective, open, inquiry with complete sharing of methods and results, the field will be left to less rigorous fringe groups here and abroad. Patients and society will suffer. [br] All of the following are the consequences of the research slowdown EXCEPT ______.
选项
A、the negative impact on technical advancement.
B、the detriment to the culture of inquiry.
C、the loss of one’s productivity.
D、the collapse of American dreams.
答案
D
解析
细节题。第四段末句指出:It might measure in the hundreds of billions of dollars,especially if one adds the lost productivity of individuals,[C]是一个后果。第五段首句提到:A less obvious,but real,cost is the damage to the fabric of America’s extraordinary culture of inquiry and technical development...,[B]和 [A]符合文意。只有[D]未提及,故为答案。
转载请注明原文地址:https://tihaiku.com/zcyy/3897365.html
相关试题推荐
Lastyear,whenPresidentGeorgeW.Bushannouncedthatfederalfundscouldb
Lastyear,whenPresidentGeorgeW.Bushannouncedthatfederalfundscouldb
Lastyear,whenPresidentGeorgeW.Bushannouncedthatfederalfundscouldb
[originaltext]TheAmericanVicePresidentDickCheneyhassaidheacceptsfu
[originaltext]TheAmericanVicePresidentDickCheneyhassaidheacceptsfu
In______,PresidentNixonmetMaoZedongandthetwocountriesissuedtheShang
[originaltext]TheTreasuryDepartmentannouncedtodaythatitisloweringth
"ThePresidentHonesty"refersto______.A、thebreak-inattheWatergatecomple
TheWatergateScandalin1973forced______toresign,thefirstpresidenttodo
[originaltext]PresidentGeorgeBushsayshewantstoshiftthedebateabout
随机试题
Nowletuslookathowweread.Whenwereadaprintedtext,oureyesmove
Paintinghasbeencontinuouslypracticedbyhumansforsome20,000years.T
[originaltext]M:Theweatherforecastsaysitwillraintoday.W:Yeah,doesn’t
下列措施中,()不能起到噪声的防治作用。A.用多孔材料装饰泵房内墙 B.隔
与客户机/服务器(Client/Server)架构相比,浏览器/服务器(
回答隧道环境检测设备检验评定的提问。(5)环境检测设备检验评定的外观质量条件有(
下列不属于科学能力探究要素的是()。A.猜想与假设 B.表达与交流 C.练
下列关于处方用量的叙述中不正确的有A.急诊处方一般不得超过3日用量B.为门(急)
关于个案管理的说法,正确的是()。A.个案管理就是社会工作者在服务过程中管理好服
纯阳温散,长于引火归元的药是A.仙茅 B.肉桂 C.丁香 D.花椒 E.
最新回复
(
0
)